While announcing the approval of its combination with Luxottica by China's anti-trust authorities, which has removed the last hurdle for the creation of a new industry giant (see separate article in this issue), Essilor reported partially positive results for the first six months of this year, defining them as “healthy” ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
To continue reading this article register now.